News from northwest biotherapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 01, 2015, 11:44 ET

NW Bio Announces Data to Date From DCVax®-Direct Phase I Trial

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

May 27, 2015, 08:30 ET

NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...

May 21, 2015, 10:56 ET

NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunotherapy

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer,...

May 06, 2015, 08:00 ET
View investor presentations 24/7 at www.virtualinvestorconferences.com.

NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7

Company invites individual and institutional investors as well as advisors to attend real-time VirtualInvestorConferences.com  Northwest...

May 01, 2015, 10:54 ET

NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Apr 20, 2015, 06:00 ET

NW Bio Featured In Presentations At the American Association for Cancer Research Annual Meeting

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...

Apr 16, 2015, 06:00 ET

NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies"

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune...

Apr 09, 2015, 08:00 ET
Northwest Biotherapeutics Logo.

NW BIO TO PRESENT AT WORLD VACCINE CONGRESS 2015

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune...

Apr 02, 2015, 11:55 ET
Northwest Biotherapeutics Logo

NW Bio Announces $40 Million Financing

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Mar 27, 2015, 09:00 ET
Northwest Biotherapeutics Logo.

NW BIO REPORTS PROMISING SURVIVAL DATA IN 51 GBM PATIENTS TREATED WITH DCVAX®-L

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...

Mar 24, 2015, 10:42 ET
Northwest Biotherapeutics Logo.

NW Bio To Present At The 2nd Immunotherapy Of Cancer Conference, ITOC-2

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer,...

Feb 19, 2015, 12:55 ET
Northwest Biotherapeutics Logo.

NW BIO'S PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER APPROVED TO PROCEED IN CANADA AND UNDER WAY AT TWO SITES

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Feb 06, 2015, 09:15 ET
Northwest Biotherapeutics Logo

NW Bio To Present At 17th Annual BIO CEO & Investor Conference

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Jan 23, 2015, 13:06 ET
Northwest Biotherapeutics Logo

NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies...

Jan 08, 2015, 14:46 ET
Northwest Biotherapeutics Logo.

NW Bio To Present At Biotech Showcase Conference

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Dec 11, 2014, 11:59 ET
Northwest Biotherapeutics Logo

NW BIO RECAPS 2014 PROGRESS, PROVIDES DCVAX-DIRECT TRIAL UPDATE AT OPPENHEIMER'S 25TH ANNUAL HEALTHCARE CONFERENCE

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Nov 19, 2014, 15:20 ET
Northwest Biotherapeutics Logo.

NW BIO ANNOUNCES FINANCINGS TOTALING $35 MILLION TO EXPAND AND ACCELERATE DCVAX®-L AND DCVAX®-DIRECT PROGRAMS

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Nov 07, 2014, 09:15 ET
Northwest Biotherapeutics Logo.

NW BIO MAKING A JOINT POSTER PRESENTATION ON ITS DCVAX-DIRECT TRIAL AT THE 29TH ANNUAL SITC MEETING

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Oct 14, 2014, 09:01 ET
Northwest Biotherapeutics Logo

DCVAX®-L HOSPITAL EXEMPTION PROGRAM NOW UNDER WAY IN GERMANY

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid...

Oct 07, 2014, 09:00 ET
Northwest Biotherapeutics Logo.  (PRNewsFoto/Northwest Biotherapeutics, Inc.)

NW BIO ANNOUNCES $11.5 MILLION FINANCING

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid...